Jackson Hole Capital Partners LLC Acquires 19,750 Shares of Enhabit, Inc. (NYSE:EHAB)

Jackson Hole Capital Partners LLC boosted its holdings in shares of Enhabit, Inc. (NYSE:EHAB) by 23.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 103,765 shares of the company’s stock after buying an additional 19,750 shares during the period. Jackson Hole Capital Partners LLC owned approximately 0.21% of Enhabit worth $1,074,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in EHAB. Deerfield Management Company L.P. Series C increased its holdings in shares of Enhabit by 3.9% in the third quarter. Deerfield Management Company L.P. Series C now owns 4,997,746 shares of the company’s stock worth $56,225,000 after buying an additional 187,943 shares during the period. Scopia Capital Management LP increased its holdings in shares of Enhabit by 9.3% in the third quarter. Scopia Capital Management LP now owns 2,091,315 shares of the company’s stock worth $23,527,000 after buying an additional 177,400 shares during the period. JANA Partners Management LP purchased a new position in shares of Enhabit in the third quarter worth about $20,532,000. Ancora Advisors LLC increased its holdings in shares of Enhabit by 414.5% in the third quarter. Ancora Advisors LLC now owns 1,705,788 shares of the company’s stock worth $19,190,000 after buying an additional 1,374,231 shares during the period. Finally, Schroder Investment Management Group increased its holdings in Enhabit by 0.8% during the 3rd quarter. Schroder Investment Management Group now owns 1,685,885 shares of the company’s stock valued at $18,966,000 after purchasing an additional 13,387 shares during the period.

Enhabit Stock Down 2.9 %

NYSE EHAB traded down $0.29 on Thursday, hitting $9.88. The stock had a trading volume of 278,357 shares, compared to its average volume of 569,422. The business’s fifty day moving average price is $10.27 and its 200 day moving average price is $9.89. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.53 and a quick ratio of 1.53. Enhabit, Inc. has a 52-week low of $7.12 and a 52-week high of $14.59. The stock has a market cap of $495.33 million, a price-to-earnings ratio of -6.28, a price-to-earnings-growth ratio of 1.57 and a beta of 1.96.

Enhabit (NYSE:EHAB) last announced its quarterly earnings data on Wednesday, March 6th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.01. The firm had revenue of $260.60 million for the quarter, compared to analyst estimates of $260.30 million. Enhabit had a negative net margin of 7.69% and a positive return on equity of 1.55%. During the same period in the previous year, the company earned $0.32 earnings per share. Equities research analysts anticipate that Enhabit, Inc. will post 0.24 earnings per share for the current year.

Analysts Set New Price Targets

EHAB has been the topic of several research reports. UBS Group raised Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price objective on the stock in a research report on Thursday, March 7th. Jefferies Financial Group dropped their price target on Enhabit from $15.00 to $14.00 and set a “buy” rating on the stock in a research report on Wednesday, March 6th. Finally, Oppenheimer restated a “market perform” rating on shares of Enhabit in a report on Thursday, March 7th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $12.08.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.